Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis (PROSPECT)
Validation of New Prognostic biomarkerRs in Patients With cirrhOsis diScharged After a hosPitalization Due to acutE deCompensation or acuTe-on-chronic Liver Failure
Sponsor: A.O.U. Città della Salute e della Scienza
Listed as NCT06855056, this observational or N/A phase trial focuses on Decompensated Cirrhosis of Liver and Liver Cirrhosis and remains actively recruiting participants. Sponsored by A.O.U. Città della Salute e della Scienza, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2025 — Sep 2025 [monthly]
Not Yet Recruiting
-
Apr 2025 — Jun 2025 [monthly]
Not Yet Recruiting
First recorded
Mar 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- A.O.U. Città della Salute e della Scienza
- Beaujon Hospital
- European Foundation for Study of Chronic Liver Failure
- Hospital Clinic de Barcelona, Barcelona, Spain
- Hospital Universitari Vall d'Hebron Research Institute
- Hospital Universitario Ramon y Cajal
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- University Hospital, Aachen
- Universität Münster
For direct contact, visit the study record on ClinicalTrials.gov .